Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew Derrick Gribble is active.

Publication


Featured researches published by Andrew Derrick Gribble.


Bioorganic & Medicinal Chemistry Letters | 2001

Solid-phase synthesis of cyclic alkoxyketones, inhibitors of the cysteine protease cathepsin K

Ashley E. Fenwick; Bénédicte Garnier; Andrew Derrick Gribble; Robert John Ife; Anthony D. Rawlings; Jason Witherington

Using solid-phase synthesis, a library of novel cyclic alkoxyketones has been constructed which show strong inhibitory activity against the cysteine protease, cathepsin K (EC 3.4.22.38).


Bioorganic & Medicinal Chemistry Letters | 2001

Diastereoselective synthesis, activity and chiral stability of cyclic alkoxyketone inhibitors of cathepsin K.

Ashley E. Fenwick; Andrew Derrick Gribble; Robert John Ife; Nichola Stevens; Jason Witherington

The diastereoselective synthesis of a novel class of cathepsin K inhibitors together with their cathepsin K affinity and stability towards aqueous buffer is reported.


Bioorganic & Medicinal Chemistry Letters | 1999

The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.

David Glynn Smith; Andrew Derrick Gribble; David Haigh; Robert John Ife; Patrick Lavery; Peter Skett; Brian Peter Slingsby; Rachel Stacey; Robert W. Ward; Andrew West

Aryl hydroxylamine derivatives have been synthesised that are some of the most potent inhibitors of hCMV protease prepared to date (IC50 14-60 nM). Mass spectrometry studies indicate that oxazinone derived hydroxylamines inhibit the enzyme by acylation of Ser132 whereas non-oxazinone derived hydroxylamines appear to inhibit via formation of a sulfinanilide at Cys138.


Journal of Medicinal Chemistry | 2003

CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach

Theo A. Berkhout; Frank E. Blaney; Angela Bridges; David Gwyn Cooper; Ian Thomson Forbes; Andrew Derrick Gribble; Pieter H. E. Groot; Adam P. Hardy; Robert John Ife; Rejbinder Kaur; Kitty Moores; Helen Shillito; Jennifer Willetts; Jason Witherington


Biochemical Journal | 1998

The role of ATP citrate-lyase in the metabolic regulation of plasma lipids Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076

Nigel J. Pearce; John W. Yates; Theo A. Berkhout; Brian Jackson; David G. Tew; Helen F. Boyd; Patrick Camilleri; Patricia Sweeney; Andrew Derrick Gribble; Anthony Shaw; Pieter H. E. Groot


Archive | 1992

Phenylderivate as inhibitors of atp citrate lyase

Andrew Derrick Gribble; Pieter H. E. Groot; Antony N. Shaw; Roland E. Dolle


Bioorganic & Medicinal Chemistry Letters | 2007

Studies towards the identification of a new generation of atypical antipsychotic agents

Vincenzo Garzya; Ian Thomson Forbes; Andrew Derrick Gribble; Mike S. Hadley; Andrew P. Lightfoot; Andrew H. Payne; Alexander Baxter Smith; Sara E. Douglas; David Gwyn Cooper; Ian Stansfield; Malcom Meeson; Emma E. Dodds; Declan N.C. Jones; Martyn D. Wood; Charlie Reavill; Carol A. Scorer; Angela Worby; Graham J. Riley; Peter Eddershaw; Chris Ioannou; Daniele Donati; Jim J. Hagan; Emiliangelo Ratti


Journal of Medicinal Chemistry | 2001

Cyclic ketone inhibitors of the cysteine protease cathepsin K.

Robert W. Marquis; Yu Ru; Jin Zeng; Robert E. Lee Trout; Stephen M. LoCastro; Andrew Derrick Gribble; Jason Witherington; Ashley E. Fenwick; Bénédicte Garnier; Thaddeus A. Tomaszek; David G. Tew; Mark E. Hemling; Chad J. Quinn; Ward W. Smith; Baoguang Zhao; Michael S. McQueney; Cheryl A. Janson; Karla J. D'Alessio; Daniel F. Veber


Journal of Medicinal Chemistry | 1996

ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme

Andrew Derrick Gribble; Roland E. Dolle; Antony N. Shaw; David McNair; Riccardo Novelli; Christine E. Novelli; Brian Peter Slingsby; Virendra P. Shah; David G. Tew; Barbara A. Saxty; Mark D. Allen; Pieter H. E. Groot; Nigel J. Pearce; John W. Yates


Journal of Medicinal Chemistry | 1998

ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. 2. Synthesis and Evaluation of (3R*,5S*)-ω-Substituted-3-carboxy-3,5-dihydroxyalkanoic Acids and Their γ-Lactone Prodrugs as Inhibitors of the Enzyme in Vitro and in Vivo

Andrew Derrick Gribble; Ife Rj; Antony N. Shaw; David McNair; Novelli Ce; Bakewell S; Virendra P. Shah; Roland E. Dolle; Pieter H. E. Groot; Nigel J. Pearce; John W. Yates; David G. Tew; Helen F. Boyd; Ashman S; Eggleston Ds; Haltiwanger Rc; Okafo G

Collaboration


Dive into the Andrew Derrick Gribble's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pieter H. E. Groot

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antony N. Shaw

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar

Ashley E. Fenwick

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David G. Tew

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar

Nigel J. Pearce

University of Hertfordshire

View shared research outputs
Researchain Logo
Decentralizing Knowledge